This inventor holds 15 USPTO granted patents, plus 5 CIPO patents and 10 EPO patents. Top assignees: Genkyotex Sa, Genkyotex Suisse Sa, Calliditas Therapeutics Suisse Sa. Active years: 2012-2026.
Location History:
- Oxfordshire, GB (2018)
- Oxon, GB (2012 - 2020)
Company Filing History:
12 out of 13 
2 out of 3 
1 out of 3 Years Active: 2012-2026
Title: Mike Orchard: Innovator in Pharmaceutical Chemistry
Introduction
Mike Orchard is a distinguished inventor based in Oxon, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various medical conditions. With a total of 15 patents to his name, Orchard's work has garnered attention in the scientific community.
Latest Patents
Among his latest inventions are pyrazolo pyridine derivatives, which serve as NADPH oxidase inhibitors. These compounds are detailed in his patent, which describes their pharmaceutical compositions and their potential use in treating disorders related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). This innovative approach highlights Orchard's commitment to advancing medical science through his research.
Career Highlights
Throughout his career, Mike Orchard has worked with notable companies, including Genkyotex SA and Genkyotex Suisse SA. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Orchard has collaborated with several professionals in his field, including Patrick Naxos Page and Francesca Gaggini. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Mike Orchard's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a leading inventor in the industry. His work continues to pave the way for advancements in medical treatments.